Lifemd Inc (LFMD) Stock Price, Quote & News - Mboum

Company Profile

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides vi...

Industry: Health Information Services

Sector: Healthcare

Phone: 866 351 5907

Website: lifemd.com

Address:

236 Fifth Avenue, Suite 400, New York, United States

thejman1 Feb. 23 at 5:19 PM

$LFMD if alex is pump posting. this stock has no bottom.

0 · Reply

Leroy_Jankins Feb. 23 at 3:50 PM

$LFMD man, is there no floor to this thing?

0 · Reply

Alex1965 Feb. 23 at 2:03 PM

$LFMD https://ir.lifemd.com/press-release-details.php?newsId=3242549

0 · Reply

Alex1965 Feb. 23 at 1:48 PM

$LFMD https://www.marketbeat.com/instant-alerts/lifemd-inc-nasdaqlfmd-receives-average-recommendation-of-moderate-buy-from-brokerages-2026-02-20/

0 · Reply

SonOfMaverick Feb. 22 at 9:16 AM

$LFMD so glad we sold worksimpli. Ai was going to crush it. Now clean balance sheet. Number 2 listed Telehealth player and we played by the rules. As the compounders get crushed, we will benefit and profitability will not be difficult.

0 · Reply

DanielTucker821 Feb. 21 at 7:12 AM

$LFMD LifeMD provides telehealth services. Growth depends on customer acquisition. Profitability remains a challenge.

0 · Reply

MarioAndretti Feb. 19 at 2:03 AM

$LFMD looks like reversal

0 · Reply

TaoistTrader Feb. 18 at 8:44 PM

$LFMD wants to go higher

0 · Reply

Stockboi_ Feb. 18 at 5:12 AM

$LFMD sick daily

0 · Reply

GuruChartist Feb. 17 at 7:43 PM

$LFMD https://www.msn.com/en-in/health/health-news/america-set-for-ozempic-explosion-as-drug-is-made-available-on-telehealth-giant-for-first-time/ar-AA1DRNJg?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1

0 · Reply

Latest News on LFMD

LifeMD to Report Fourth Quarter 2025 Financial Results on March 9

Feb 23, 2026, 8:00 AM EST - 5 hours ago

LifeMD to Report Fourth Quarter 2025 Financial Results on March 9

LifeMD: Pure Telehealth Play With In-House Pharmacy Integration

Feb 2, 2026, 4:15 PM EST - 20 days ago

LifeMD: Pure Telehealth Play With In-House Pharmacy Integration

LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A.

Jan 6, 2026, 8:30 AM EST - 6 weeks ago

LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A.

LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill

Jan 5, 2026, 8:05 AM EST - 7 weeks ago

LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Dec 26, 2025, 8:00 AM EST - 2 months ago

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME's America's Growth Leaders of 2026

Nov 24, 2025, 8:00 AM EST - 3 months ago

LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME's America's Growth Leaders of 2026

LifeMD, Inc. (LFMD) Q3 2025 Earnings Call Transcript

Nov 17, 2025, 8:47 PM EST - 3 months ago

LifeMD, Inc. (LFMD) Q3 2025 Earnings Call Transcript

LifeMD Stock Plummets After Q3 Earnings: Here's Why

Nov 17, 2025, 4:49 PM EST - 3 months ago

LifeMD Stock Plummets After Q3 Earnings: Here's Why

LifeMD Reports Third Quarter 2025 Results

Nov 17, 2025, 4:05 PM EST - 3 months ago

LifeMD Reports Third Quarter 2025 Results

LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk

Nov 17, 2025, 8:00 AM EST - 3 months ago

LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk

LifeMD to Participate in the BTIG Digital Health Forum

Nov 10, 2025, 8:00 AM EST - 3 months ago

LifeMD to Participate in the BTIG Digital Health Forum

LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17

Nov 5, 2025, 5:15 PM EST - 3 months ago

LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17

LifeMD Divests Majority Interest in WorkSimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy Platform

Nov 4, 2025, 9:15 AM EST - 3 months ago

LifeMD Divests Majority Interest in WorkSimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy Platform

LifeMD (LFMD) Faces Lawsuit Over Alleged Concealment of Cost and Refund Woes in Key Segments, According to Hagens Berman

Oct 24, 2025, 1:43 PM EDT - 4 months ago

LifeMD (LFMD) Faces Lawsuit Over Alleged Concealment of Cost and Refund Woes in Key Segments, According to Hagens Berman

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD

Oct 23, 2025, 1:12 PM EDT - 4 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD

LifeMD to Report Third Quarter 2025 Financial Results on November 6

Oct 23, 2025, 8:00 AM EDT - 4 months ago

LifeMD to Report Third Quarter 2025 Financial Results on November 6

LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women's Health Program

Oct 22, 2025, 8:00 AM EDT - 4 months ago

LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women's Health Program

LifeMD (LFMD) Sued for Allegedly Misleading Investors on Growth Guidance, According to Hagens Berman

Oct 13, 2025, 4:00 PM EDT - 4 months ago

LifeMD (LFMD) Sued for Allegedly Misleading Investors on Growth Guidance, According to Hagens Berman

LFMD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD

Oct 12, 2025, 8:42 AM EDT - 4 months ago

LFMD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD

Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman

Oct 10, 2025, 9:02 AM EDT - 4 months ago

Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 25, 2025 in LifeMD, Inc. Lawsuit - LFMD

Oct 9, 2025, 8:45 AM EDT - 4 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 25, 2025 in LifeMD, Inc. Lawsuit - LFMD

LifeMD (LFMD) Sued for Allegedly Misleading Investors on Growth Guidance According to Hagens Berman

Oct 6, 2025, 5:01 PM EDT - 4 months ago

LifeMD (LFMD) Sued for Allegedly Misleading Investors on Growth Guidance According to Hagens Berman

LIFEMD DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges LifeMD Investors to Contact the Firm Before the October 27th Deadline

Oct 6, 2025, 2:27 PM EDT - 4 months ago

LIFEMD DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges LifeMD Investors to Contact the Firm Before the October 27th Deadline

LifeMD to offer Novo's Ozempic at $499 per month to eligible US cash-paying customers

Sep 30, 2025, 8:14 AM EDT - 5 months ago

LifeMD to offer Novo's Ozempic at $499 per month to eligible US cash-paying customers

LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk

Sep 30, 2025, 8:00 AM EDT - 5 months ago

LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk

Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements According to Hagens Berman

Sep 26, 2025, 2:57 PM EDT - 5 months ago

Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements According to Hagens Berman

LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

Sep 25, 2025, 4:06 PM EDT - 5 months ago

LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

LifeMD: Set To Ride A Telehealth Tailwind

Sep 24, 2025, 10:27 AM EDT - 5 months ago

LifeMD: Set To Ride A Telehealth Tailwind

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD

Sep 21, 2025, 7:49 AM EDT - 5 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD

LifeMD, Inc. Investors: Company Investigated by the Portnoy Law Firm

Sep 18, 2025, 1:37 PM EDT - 5 months ago

LifeMD, Inc. Investors: Company Investigated by the Portnoy Law Firm

LifeMD Expands Pharmacy Services with Non-Sterile Compounding to Deliver Personalized, Cost-Efficient Therapies at Scale

Sep 18, 2025, 8:00 AM EDT - 5 months ago

LifeMD Expands Pharmacy Services with Non-Sterile Compounding to Deliver Personalized, Cost-Efficient Therapies at Scale

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against LifeMD, Inc. (LFMD)

Sep 17, 2025, 8:00 PM EDT - 5 months ago

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against LifeMD, Inc. (LFMD)

thejman1 Feb. 23 at 5:19 PM

$LFMD if alex is pump posting. this stock has no bottom.

0 · Reply

Leroy_Jankins Feb. 23 at 3:50 PM

$LFMD man, is there no floor to this thing?

0 · Reply

Alex1965 Feb. 23 at 2:03 PM

$LFMD https://ir.lifemd.com/press-release-details.php?newsId=3242549

0 · Reply

Alex1965 Feb. 23 at 1:48 PM

$LFMD https://www.marketbeat.com/instant-alerts/lifemd-inc-nasdaqlfmd-receives-average-recommendation-of-moderate-buy-from-brokerages-2026-02-20/

0 · Reply

SonOfMaverick Feb. 22 at 9:16 AM

$LFMD so glad we sold worksimpli. Ai was going to crush it. Now clean balance sheet. Number 2 listed Telehealth player and we played by the rules. As the compounders get crushed, we will benefit and profitability will not be difficult.

0 · Reply

DanielTucker821 Feb. 21 at 7:12 AM

$LFMD LifeMD provides telehealth services. Growth depends on customer acquisition. Profitability remains a challenge.

0 · Reply

MarioAndretti Feb. 19 at 2:03 AM

$LFMD looks like reversal

0 · Reply

TaoistTrader Feb. 18 at 8:44 PM

$LFMD wants to go higher

0 · Reply

Stockboi_ Feb. 18 at 5:12 AM

$LFMD sick daily

0 · Reply

GuruChartist Feb. 17 at 7:43 PM

$LFMD https://www.msn.com/en-in/health/health-news/america-set-for-ozempic-explosion-as-drug-is-made-available-on-telehealth-giant-for-first-time/ar-AA1DRNJg?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1

0 · Reply

RiskDecay Feb. 17 at 2:33 PM

$LFMD LifeMD telehealth; regulatory scrutiny, high CAC, competitive DTC healthcare.

0 · Reply

GuruChartist Feb. 15 at 2:13 PM

$LFMD Ugly chart

0 · Reply

Alex1965 Feb. 13 at 7:48 PM

$LFMD https://www.cnbc.com/2026/02/11/novo-nordisk-ceo-medicare-coverage-opens-15-million-patient-opportunity.html

0 · Reply

GuruChartist Feb. 13 at 3:25 AM

$LFMD https://simplywall.st/stocks/us/healthcare/nasdaq-lfmd/lifemd/news/why-investors-shouldnt-be-surprised-by-lifemd-incs-nasdaqlfm

0 · Reply

SCNC Feb. 12 at 9:26 PM

$GDRX $LFMD $WW $HIMS Broad selloffs, and/or specific manipulation, always create some good buying opportunities.. The telehealth play of approved oral GLP-1's could offer significant upside going forward, considering the size of the market.. and these companies current market cap (could be a sign jumpstart for these smaller providers)

0 · Reply

TaoistTrader Feb. 12 at 8:52 PM

$LFMD wow really bad

0 · Reply

Leroy_Jankins Feb. 12 at 6:31 PM

$LFMD stock down 90% in 5 yrs

0 · Reply

spactrader999 Feb. 12 at 6:14 PM

$LFMD HIMS going down I thought is good for LFMD as they are dealing with NVO directly. They have no debt as well. What are the chances of Bankruptcy?

0 · Reply

Dragos Feb. 12 at 5:03 PM

$LFMD very disappointed in management. Months without news, without anything public. While the stock does this.

0 · Reply

Fatzburger Feb. 12 at 3:34 PM

$LFMD No idea what LifeMD has done to earn such opprobrium. Far too low.

0 · Reply

SonOfMaverick Feb. 11 at 9:31 PM

$LFMD No stress. 30 bucks. Then 100 bucks.

0 · Reply

Leroy_Jankins Feb. 11 at 9:18 PM

$LFMD this thing is like portfolio cancer

0 · Reply